UNICHEMLAB

The stock has been placed in Additional Surveillance Measure (ASM) list STASM - I (11).

Unichem Laboratories Ltd.

NSE: UNICHEMLAB

BSE: 506690

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

589.05-15.8 (-2.61%)

17 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

56.9 / 100

Value Score

75.7 / 100

Price Momentum Score

66.1 / 100

QVM Score

81.8 / 100

Key Metrics

Market Cap

4147.27

P/E (TTM)

16.40

P/B

1.53

P/S (TTM)

1.88

EV/EBITDA

23.61

CAPE (5Y)

138.44

ROE (TTM)

9.78

ROCE (TTM)

1.93

ROA (TTM)

6.92

Avg 3Y ROE

4.19

Earnings 3Y CAGR

Sales 3Y CAGR

17.91

Sales 5Y CAGR

12.26

Debt/Equity

0.18

Consensus TP

Strong Buy %

Promoter Holding

70.22

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Unichem Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 16.4 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -46.89%

What is P/E Ratio?

Median: 30.88

Value 16.4

-44.893379.36

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 84.1% for 12-month ended 31 Mar 2026 and the growth was 75.98 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.18 as on 31 Mar 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year

What is Debt to Equity?

Negative

Low and declining operating margin

The company reported low operating margin of 2.68% for 12-month ended 31 Mar 2026 and operating margin declined by -397 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of 4.31% for 12-month ended 31 Mar 2026 and the growth was 6.92 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 11.23

Value 4.31

-82.35114662

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low ROE but improving trend

The company reported low ROE of 9.78% for 12-month ended 31 Mar 2026 but ROE improved by 407 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 49.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

49.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Unichem Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Unichem Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Unichem Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	50.74	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	70.21	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22
Indian Promoter	50.74	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	50.93	70.21	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22	70.22
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	11.22	10.84	10.77	10.63	10.44	10.63	10.62	10.75	11.06	11.03	10.41	9.76	9.86	11.26	10.84	11.31	12.17	12.47	12.61	12.68	12.30	11.90	11.75	11.73	11.63	11.36
Mutual Funds / UTI	8.82	8.28	8.28	8.18	8.18	8.18	8.18	8.18	8.18	8.08	7.29	6.78	6.69	6.11	8.56	9.03	9.77	10.14	10.22	10.20	9.89	9.39	9.17	9.17	9.07	9.32
FI/Bank/Insurance	0.64	0.60	0.44	0.44	0.30	0.30	0.30	0.30	0.30	0.30	0.26	0.27	0.26	1.29	0.26	0.26	0.26	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25	0.25
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	1.76	1.61	1.59	1.55	1.50	1.54	1.53	1.45	1.47	1.50	1.71	1.56	1.70	1.62	0.83	0.84	0.90	0.89	0.94	1.05	0.98	0.98	1.00	0.99	1.00	0.90
Other Institutions	0.00	0.36	0.45	0.45	0.46	0.61	0.61	0.82	1.10	1.15	1.15	1.16	1.21	2.25	1.18	1.17	1.23	1.18	1.18	1.18	1.18	1.28	1.33	1.31	1.31	0.89
Non-Institution	38.04	38.23	38.29	38.44	38.62	38.43	38.44	38.32	38.01	38.04	38.66	39.30	39.21	37.80	18.95	18.47	17.61	17.30	17.18	17.10	17.48	17.88	18.03	18.05	18.15	18.42
Bodies Corporate	3.76	3.64	3.15	2.80	2.75	2.62	2.46	2.47	2.47	1.18	3.12	3.21	1.63	4.81	0.42	0.40	0.35	0.31	0.45	0.34	0.36	0.39	0.40	0.46	0.46	0.40
Others (incl. Retail) No. of shareholders	34.28 35,935	34.59 37,084	35.14 37,712	35.64 37,767	35.87 33,420	35.81 33,960	35.98 33,594	35.85 35,022	35.54 33,274	36.86 32,399	35.54 29,273	36.09 30,286	37.58 29,128	32.99 26,290	18.53 21,379	18.07 20,669	17.26 20,974	16.99 20,427	16.73 20,160	16.76 21,260	17.12 21,426	17.49 22,792	17.63 23,370	17.59 23,060	17.69 23,183	18.02 25,154

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Unichem Laboratories Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
VANDANA PANDEY Employee	August-2023	Market Sale (Disposal) 24th Aug 2023	0.01 %	₹ 406.74	6.00 k	₹ 24.40 lac
DILIP KUNKOLIENKAR Director	August-2023	Market Sale (Disposal) 23rd Aug 2023	0.01 %	₹ 408.22	5.00 k	₹ 20.41 lac
DILIP KUNKOLIENKAR Director	August-2023	Market Sale (Disposal) 21st Aug 2023	0.01 %	₹ 407.40	5.00 k	₹ 20.37 lac
DILIP KUNKOLIENKAR Director	August-2023	Market Sale (Disposal) 17th Aug 2023	0.06 %	₹ 404.44	30.00 k	₹ 1.21 cr
JALESH BURYE Employee	August-2023	Market Sale (Disposal) 16th Aug 2023	0.00 %	₹ 401.64	3.34 k	₹ 13.41 lac
DILIP KUNKOLIENKAR Director	August-2023	Market Sale (Disposal) 9th Aug 2023	0.08 %	₹ 397.00	16.26 k	₹ 64.55 lac
DILIP KUNKOLIENKAR Director	August-2023	Market Sale (Disposal) 2nd Aug 2023	0.10 %	₹ 397.03	19.00 k	₹ 75.44 lac
VERA MAHAJAN Directors Immediate Relative	July-2023	Market Sale (Disposal) 27th Jul 2023	0.00 %	₹ 378.13	2.84 k	₹ 10.72 lac
ANAND MAHAJAN Director	July-2023	Market Sale (Disposal) 27th Jul 2023	0.00 %	₹ 378.55	3.03 k	₹ 11.47 lac
VERA MAHAJAN Directors Immediate Relative	July-2023	Market Sale (Disposal) 25th Jul 2023	0.00 %	₹ 379.47	2.00 k	₹ 7.59 lac

Corporate Actions

History of Unichem Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 4/share
Record date: 2nd Aug 2022Ex-date: 1st Aug 2022
Announced on: 27th May 2022
Dividend₹ 4/share
Record date: 24th Jul 2021Ex-date: 22nd Jul 2021
Announced on: 29th May 2021
Dividend₹ 4/share
Record date: 22nd Aug 2020Ex-date: 20th Aug 2020
Announced on: 19th Jun 2020
Dividend₹ 4/share
Record date: 20th Jul 2019Ex-date: 18th Jul 2019
Announced on: 24th May 2019
Dividend₹ 5/share
Record date: 21st Jul 2018Ex-date: 19th Jul 2018
Announced on: 29th May 2018

Company Profile

Overview of Unichem Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmace...

Key personnel

Mr. Sanjay Jain

Chief Financial Officer

Mr. Pradeep Bhandari

Compliance Officer, Company Secretary and Head Legal

Dr. Prakash Amrut Mody, Ph.D.D

Non-Executive Non-Independent Chairman of the Board

Mr. Pabitrakumar Kalipada BhattacharyyaD

Managing Director, Executive Director

Mr. Pranay Premchand GodhaD

Non-Executive Non-Independent Director

Dr. Swati PatankarD

Additional Independent Director

Mr. Anand KusreD

Non-Executive Independent Director

Mr. Arun TodarwalD

Non-Executive Independent Director

View all

Incorporated on

22 Aug 1962

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

2,815

IPO date

10 Jan 1995

Free Float

2,02,13,041

Website

https://www.unichemlabs.com/

Phone no.

+912266888333

Address

47, KANDIVLI INDUSTRIAL ESTATE, KANDIVALI WEST, , 400067, India

Frequently Asked Questions

What is the current share price of Unichem Laboratories Ltd.?

The current share price of Unichem Laboratories Ltd. is ₹ 589.05 as of 17 Jul 2026.

What is the market capitalisation of Unichem Laboratories Ltd.?

The market capitalisation of Unichem Laboratories Ltd. stands at ₹ 4,147.27 Cr.

What is the PE ratio of Unichem Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Unichem Laboratories Ltd. is 16.40 as of the latest trailing twelve months data.

What is the ROE and ROCE of Unichem Laboratories Ltd.?

Unichem Laboratories Ltd. has a Return on Equity (ROE) of 9.78% and a Return on Capital Employed (ROCE) of 1.93% as per the latest financial reports.

What is the 52-week high and low of Unichem Laboratories Ltd.?

The 52-week high of Unichem Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Unichem Laboratories Ltd.?

The dividend yield of Unichem Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Unichem Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.90%, Domestic Institutional Investors (DII) hold 9.57% and retail/public investors hold 18.02% of Unichem Laboratories Ltd. shares.

What sector does Unichem Laboratories Ltd. belong to?

Unichem Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Unichem Laboratories Ltd.?

The beta of Unichem Laboratories Ltd. is 0.66, indicating its price volatility relative to the broader market. Over the past 1 year, Unichem Laboratories Ltd. has delivered an absolute return of -2.64%.

What is the RSI of Unichem Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Unichem Laboratories Ltd. is 65.84, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Unichem Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Unichem Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions